Evidence map›Paper›PMID 21461926›Full record

ArticleEcotoxicology (London, England)2011

Fitness costs of resistance to Bti toxins in the dengue vector Aedes aegypti.

Margot Paris, Jean-Philippe David, Laurence Despres

Abstract read
PubMed Publisher
In one paragraph

Article in Ecotoxicology (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Viruses · 2022
    Article
  6. Article
  7. Genetic Stability and Fitness ofFrontiers in bioengineering and biotechnology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Margot ParisLaboratoire d'Ecologie Alpine, UMR CNRS 5553, Université Joseph Fourier, BP 53, 38041, Grenoble Cedex 09, France. margotparis1@gmail.com
Jean-Philippe David
Laurence Despres
Centre National de la Recherche Scientifique · FRLaboratoire d'Écologie Alpine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustainable insect vector disease control strategies involve delaying the evolution of resistance to insecticides in natural populations. The evolutionary dynamics of resistance in the field is highly dependent on the fitness cost of resistance alleles. To successfully manage resistance evolution in target species, it is not only important to find evidence of fitness cost in resistant insects, but also to determine at which stage of the insect's life it is expressed. Here, we show that resistance costs to the bacterio-insecticide Bacillus thuringiensis subsp. israelensis (Bti) are expressed at all the life-stages of the dengue vector Aedes aegypti, including egg survival, larval development time, and female fecundity. We show that the storage of eggs for 4 months is long enough to counter-select resistance alleles. This suggests that Bti resistance is not likely to evolve in temperate climates where most mosquito species overwinter as eggs. In tropical regions with a rapid turn-over of generations, resistance alleles are likely to be counter-selected in only few generations without treatment through fitness costs expressed in terms of larval development time and female fecundity. We discuss the implications of our findings in terms of sustainable management strategies in light of the challenge of preserving the long-term efficiency of this environmentally safe anti-mosquito bio-insecticide.

Indexed as

AedesAnimalsBacillus thuringiensisBacterial ToxinsDengueDrug ResistanceFemaleFertilityInsect VectorsMalePest Control, BiologicalBacterial Toxins

Identifiers

PMID21461926
OpenAlexW2069188201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.